Evidence map›Paper›PMID 40260400›Full record

ArticleCase reports in infectious diseases2025

A Case Report of COVID-19 With Tracheobronchial Aspergillosis.

Haolei Liu, Hailu Jiao, Jun Feng, Hui Gao, Shikui Wu

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Haolei LiuDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Hunan Traditional Chinese Medicine College, Zhuzhou, Hunan, China.ORCID https://orcid.org/0000-0003-4345-980X
Hailu JiaoDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Hunan Traditional Chinese Medicine College, Zhuzhou, Hunan, China.ORCID https://orcid.org/0009-0007-6498-7464
Jun FengDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Hunan Traditional Chinese Medicine College, Zhuzhou, Hunan, China.ORCID https://orcid.org/0009-0004-8224-8153
Hui GaoDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Hunan Traditional Chinese Medicine College, Zhuzhou, Hunan, China.ORCID https://orcid.org/0009-0008-3265-2747
Shikui WuDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Hunan Traditional Chinese Medicine College, Zhuzhou, Hunan, China.ORCID https://orcid.org/0009-0005-5463-1427

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The concurrence of COVID-19 and tracheobronchial aspergillosis (TBA) is rarely documented in clinical practice. This report presents a case of TBA in a patient diagnosed with COVID-19 prior to the administration of immunosuppressive agents. This case underscores the necessity of considering fungal infections in patients with COVID-19, even during the early stages of the disease. The combination of timely bronchoscopy, antiviral therapy, and antifungal treatment resulted in favorable therapeutic outcomes for the patient.

Identifiers

PMID40260400
PMCPMC12009674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.